VIA
COGT icon

Virtus Investment Advisers’s Cogent Biosciences COGT Stock Holding History

Virtus Investment Advisers’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Buy
9,885
+3,409
+53% +$119K 0.09% 307
2026
Q1 		$249K Buy
6,476
+159
+3% +$5.87K 0.07% 315
2025
Q4 		$224K Sell
6,317
-9,443
-60% -$265K 0.06% 363
2025
Q3 		$226K Buy
15,760
+2,736
+21% +$32.4K 0.06% 250
2025
Q2 		$93.5K Sell
13,024
-6,663
-34% -$36.9K 0.03% 361
2025
Q1 		$118K Buy
+19,687
New +$154K 0.03% 396

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Virtus Investment Advisers's COGT Position: Q2 2026 in Review

Virtus Investment Advisers increased its Cogent Biosciences (COGT) stake by 53% in Q2 2026, buying an estimated $119K and bringing the position to 9,885 shares worth $383K. The position accounts for 0.09% of the portfolio, ranked #307.

Virtus Investment Advisers first reported a position in COGT in Q1 2025 and has held it in 6 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Virtus Investment Advisers held 9,885 shares of Cogent Biosciences worth $383K as of Q2 2026.
  • Virtus Investment Advisers bought 3,409 Cogent Biosciences shares in Q2 2026, an estimated $119K.
  • Cogent Biosciences made up 0.09% of Virtus Investment Advisers's portfolio in Q2 2026, its #307 holding.
  • Virtus Investment Advisers first reported a position in Cogent Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.